换一批Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
第一作者：
Dworkin,R.H.
作者：
Dworkin,R.H. [1]
;
Turk,D.C. [2]
;
Peirce-Sandner,S. [3]
;
Burke,L.B. [4]
;
Farrar,J.T. [5]
;
Gilron,I. [6]
;
Jensen,M.P. [7]
;
Katz,N.P. [8]
;
Raja,S.N. [9]
;
Rappaport,B.A. [10]
;
Rowbotham,M.C. [11]
;
Backonja,M.-M. [12]
;
Baron,R. [13]
;
Bellamy,N. [14]
;
Bhagwagar,Z. [15]
;
Costello,A. [16]
;
Cowan,P. [17]
;
Fang,W.C. [18]
;
Hertz,S. [19]
;
Jay,G.W. [20]
;
Junor,R. [21]
;
Kerns,R.D. [22]
;
Kerwin,R. [23]
;
Kopecky,E.A. [24]
;
Lissin,D. [25]
;
Malamut,R. [26]
;
Markman,J.D. [27]
;
McDermott,M.P. [28]
;
Munera,C. [29]
;
Porter,L. [30]
;
Rauschkolb,C. [31]
;
Rice,A.S.C. [32]
;
Sampaio,C. [33]
;
Skljarevski,V. [34]
;
Sommerville,K. [35]
;
Stacey,B.R. [36]
;
Steigerwald,I. ;
Tobias,J. ;
Trentacosti,A.M. ;
Wasan,A.D. ;
Wells,G.A. ;
Williams,J. ;
Witter,J. ;
Ziegler,D.
作者单位：
University of Washington, Seattle, WA, United States
[1]
Analgesic Solutions, Natick, MA, United States, Tufts University, Boston, MA, United States
[2]
University of Kiel, Kiel, Germany
[3]
Nuvo Research, West Chester, PA, United States
[4]
German Diabetes Center, Heinrich Heine University, Düsseldorf, Germany
[5]
National Institutes of Health, Bethesda, MD, United States
[6]
Endo Pharmaceuticals Inc., Chadds Ford, PA, United States
[7]
AstraZeneca, Wilmington, DE, United States
[8]
Pfizer, New London, CT, United States
[9]
Grünenthal GmbH, Aachen, Germany
[10]
University of Ottawa, Ottawa, ON, Canada
[11]
Imperial College, London, United Kingdom
[12]
California Pacific Medical Center Research Institute, San Francisco, CA, United States
[13]
Faculdade de Medicina de Lisboa, Lisbon, Portugal
[14]
Harvard Medical School, Boston, MA, United States
[15]
University of Pennsylvania, Philadelphia, PA, United States
[16]
Johnson and Johnson Pharmaceutical Research and Development, Titusville, NJ, United States
[17]
Queen's University, Kingston, ON, Canada
[18]
Johns Hopkins University, Baltimore, MD, United States
[19]
Durect Corporation, Cupertino, CA, United States
[20]
Eisai Limited, Mosquito Way, Hatfield, United Kingdom
[21]
American Chronic Pain Association, Rocklin, CA, United States
[22]
University of Rochester, Rochester, NY, United States
[23]
Smith and Nephew, Durham, NC, United States
[24]
United States Food and Drug Administration, Silver Spring, MD, United States
[25]
Department of Veterans Affairs, West Haven, CT, United States, Yale University, New Haven, CT
[26]
Purdue Pharma, Stamford, CT, United States
[27]
University of Wisconsin, Madison, WI, United States
[28]
DePuy Spine, Raynham, MA, United States
[29]
King Pharmaceuticals, Pfizer, Cary, NC, United States
[30]
Bristol-Myers Squibb, Wallingford, CT, United States
[31]
University of Queensland, Brisbane, Australia
[32]
Oregon Health and Science University, Portland, OR, United States
[33]
NeurogesX, Inc., San Carlos, CA, United States
[34]
Departments of Anesthesiology and Neurology, Center for Human Experimental Therapeutics, University
[35]
Eli Lilly and Co., Indianapolis, IN, United States
[36]
发布时间
2013-11-20
- 浏览2
Pain
Pain
1148-1158页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
